Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Wins Case Against Advanced Materials

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today said that the Delaware Court of Chancery has ruled in its favor in a trade secrets and breach of contract suit that it had brought against Advanced Materials Technology.

The lawsuit, which was filed in January 2008, centered on the firm's high-performance liquid chromatography technology. In that suit, Agilent alleged that three former employees, who were subsequently employed by AMT, misappropriated Agilent's trade secrets and thereby had breached their confidentiality agreements and fiduciary duties to their former employers.

Agilent said in its statement today that the court ruled that AMT had "illegally used trade secrets and confidential information in developing its Halo HPLC columns."

In addition, Agilent said that the court had ruled that AMT is liable for monetary damages and reasonable attorneys' fees and costs incurred by Agilent as a result of the "willful and malicious conduct."

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.